Medical Patent News

RSS

Labopharm comments on outcome of patent-infringement litigation initiated by Purdue Pharma

Labopharm Inc. today commented on the outcome of patent-infringement litigation initiated by Purdue Pharma Products L.P. against Par Pharmaceutical Companies, Inc. relating to Ultram(R) ER (tramadol hydrochloride extended-release tablets).

17 Aug 2009

Align Technology settles patent litigation with Ormco

Align Technology, Inc. today announced that it has reached a settlement with Ormco Corporation (Ormco), a subsidiary of Danaher Corporation, to end all pending litigation between the parties and to begin a new strategic collaboration.

From Danaher 17 Aug 2009

Acacia subsidiary acquires rights to biosensor patent

Acacia Research Corporation (Nasdaq:ACTG) announced today that its subsidiary, Acacia Patent Acquisition LLC, has acquired rights to a patent for biosensor technology.

13 Aug 2009

Dimera granted peripheral artery disease patent

The U.S. Patent and Trade Office (USPTO) plans to announce patent award approval on August 11 to Dimera Incorporated for treatment of symptoms of Peripheral Arterial Disease (PAD), which is alternatively known as Peripheral Vascular Disease (PVD).

12 Aug 2009

Metabolon awarded patent for metabolomics software

Metabolon, Inc. has announced that it has been awarded a patent for its metabolomics software, Ion Tracker™, which provides a mechanism for creating new chemical library entries.

11 Aug 2009

Somanetics files patent infringement against CAS Medical Systems

Somanetics Corporation (Nasdaq: SMTS), a developer, manufacturer and marketer of the INVOS(R) Cerebral/Somatic Oximeter, a medical device that monitors oxygen saturation in the brain and other regions of the body, announced that it has filed a patent infringement action against CAS Medical Systems, Inc. in the United States District Court for the Eastern District of Michigan.

11 Aug 2009

Oncogenex Pharmaceuticals issued key patent

OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI), today announced that the United States Patent and Trademark Office (PTO) has issued United States Patent Number 7,569,551 entitled "Chemo-and Radiation-sensitization of Cancer by Antisense TRPM-2 Oligodeoxynucleotides," on the method of using OncoGenex' lead cancer drug candidate, OGX-011, to treat certain cancers.

10 Aug 2009

AGA Medical announces verdict in jury phase of patent case

AGA Medical Holdings, Inc. (AGA Medical) today announced the completion of the first phase of a litigation between AGA Medical and Medtronic, Inc., in which a California jury returned a verdict that some of AGA Medical's products infringed some of the claims of patents held by Medtronic, and that these patents have not been proven invalid over prior art.

6 Aug 2009

Appeals court affirms invalidation of Yasmin patent

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed a ruling by the U.S. District Court for the District of New Jersey finding Bayer Schering's U.S. Patent No. 6,787,531 invalid. The patent is listed in the Orange Book for Bayer's oral contraception Yasmin®.

5 Aug 2009

China-Biotics applies for patents on new probiotic formulations

China-Biotics, Inc. today announced it has submitted applications for four patents to the State Intellectual Property Office of the People's Republic of China.

31 Jul 2009

Patent Office upholds I-Flow Corporation’s patent covering infusion devices

The United States Patent and Trademark Office has once again affirmed the validity of I-Flow Corporation's patent covering the ON-Q compact collapsible infusion devices.

28 Jul 2009

Cytori Therapeutics comments on patent appeal

Cytori Therapeutics has been informed that the United States Federal Court in the Central District of California upheld a June 2008 decision relating to U.S. patent number 6,777,231 (the '231 patent).

26 Jul 2009

Nanosys reaches settlement of patent infringement lawsuit against Nanoco Technologies

Nanosys, Inc. today announced it has agreed to settlement terms of a patent infringement lawsuit against Nanoco Technologies Ltd.

23 Jul 2009

NovaSterilis receives patent for vaccine creation using supercritical carbon dioxide

NovaSterilis Inc., a developer of supercritical carbon dioxide technology for biomedical applications, announces the issue of US Patent 7,560,113 for creation and production of whole cell vaccines with supercritical carbon dioxide (SCCO2)*.

22 Jul 2009

Watson confirms new drug application for generic Sanctura XR

Watson Pharmaceuticals, Inc. has confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its trospium chloride extended-release 60 mg capsules prior to the expiration of a patent owned by Supernus Pharmaceuticals, Inc.

15 Jul 2009

Circadian Technologies granted significant European patent

Circadian Technologies Limited (ASX:CIR) announced today that its subsidiary company, Vegenics Limited, has been granted European Patent 1749836 covering the use of VEGF-D protein and antibodies to VEGF-D in a broad spectrum of therapeutic indications, including the treatment of cancer.

17 Jun 2009

Misonix purchase patents from ProRhythm

Misonix, Inc. has announced that it has purchased three patents associated with High Intensity Focused Ultrasound ("HIFU") technology from ProRhythm, Inc.

14 Jun 2009

Impliant granted two new U.S. patents - successfully defends European patent

Impliant, Inc., a developer of novel spine arthroplasty alternatives to fusion surgery, today announced that the European Patent Office has confirmed the validity of one of its key patents following an Opposition by Archus Orthopedics, Inc. (Redmond, WA) that concluded with oral proceedings on May 12, 2009 in Munich, Germany.

9 Jun 2009

Medtronic announces appeal decision in patent case with DePuy Spine

Medtronic, Inc. has announced results from a Federal Circuit Court review of a December 2007 patent infringement verdict regarding the Vertex line of multiaxial screws, which are no longer on the market.

1 Jun 2009

New U.S. patent issued for Limbrel in osteoarthritis

Primus Pharmaceuticals, Inc. has announced the issuance of a new composition of matter patent for Limbrel, the first prescription medical food product to safely meet the distinctive nutritional requirements of patients with osteoarthritis (OA). U.S. Patent #7,514,469 was recently issued by the U.S. Patent and Trademark Office.

27 May 2009